• For Researchers

Speaking a thousand words – how a cancer image collection is set to improve AI diagnosis

Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection

8 September 2021

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021

• For Researchers

The (un)usual suspects – how early detection research embraces interdisciplinary science

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

20 August 2021

• For Researchers

On your marks, get set… start-up!

Explore three of the latest companies to come out of one of our entrepreneurial programmes. Explore three of the latest companies to come out of one of our entrepreneurial programmes.

13 August 2021

• Science & Technology
• Health & Medicine
• For Researchers

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

10 August 2021

• For Researchers

The right combination for early detection

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field

4 August 2021

• Science & Technology
• For Researchers

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

28 July 2021

• For Researchers

A vision for the next decade of UK life sciences

What could the government’s Life Sciences Vision mean for cancer research? What could the government’s Life Sciences Vision mean for cancer research?

21 July 2021

• For Researchers

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

2 July 2021

• For Researchers

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome. Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.

2 June 2021

• For Researchers

Cancer clinical trials – learning lessons from the COVID-19 pandemic

After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt

20 May 2021

• For Researchers

Mitochondrial DNA in cancer: small genome, big impact

Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics. Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.

5 May 2021